Physician profile
Audrey Goh
NPI 1972274280
$951.74
in general payments reported to CMS, 2019-2025
18 companies · $603 in 2025
The $603 reported for 2025 was more than what 78% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $184 · 2024: $164 · 2025: $603.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $952.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $951.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $171.99 | 2025 | Intracept |
| Amgen INC. | $95.16 | 2023-2025 | Tavneos, Krystexxa |
| Akebia Therapeutics INC | $90.30 | 2025 | Vafseo |
| Astrazeneca Pharmaceuticals LP | $66.90 | 2024-2025 | Lokelma, Farxiga |
| Glaxosmithkline, LLC. | $64.46 | 2023-2024 | Jesduvroq, Benlysta |
| Takeda Pharmaceuticals U.S.A., INC. | $63.08 | 2023-2024 | Livtencity |
| Ardelyx, INC. | $61.96 | 2025 | Xphozah 30 Mg |
| Novartis Pharmaceuticals Corporation | $59.97 | 2024-2025 | |
| Mallinckrodt Hospital Products INC. | $53.57 | 2025 | Acthar |
| Vifor Pharma, INC. | $47.82 | 2023 | Veltassa |
| Veloxis Pharmaceuticals, INC. | $28.46 | 2025 | Envarsus |
| Bayer Healthcare Pharmaceuticals INC. | $28.46 | 2023-2025 | |
| Novo Nordisk INC | $27.95 | 2024 | Rivfloza |
| Renalytix Ai, INC. | $26.67 | 2025 | Kidneyintelx Blood Collection Convenience Kit |
| Fresenius USA Marketing, INC. | $18.34 | 2023 | Korsuva, Velphoro |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Travere Therapeutics, INC. | $16.44 | 2023 | |
| Daiichi Sankyo INC. | $15.74 | 2023 | Injectafer |
| Otsuka America Pharmaceutical, INC. | $14.47 | 2025 | Jynarque |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Audrey Goh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.